UNC scientists describe protein that protects against colon cancer

April 18, 2012

A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

The NLR family of proteins is very complex and scientists have determined that the majority of them act as activators of . However, scientists at UNC and elsewhere have recently reported that one NLR protein, NLRP12, actually functions to reduce disease by inhibiting a major inflammatory pathway mediated by a called NF-Kappa B. NF-Kappa B activation has been long associated with inflammation and cancer promotion. But NF-Kappa B has an alternate signaling pathway that is not as well understood.  This alternative pathway was the focus of the UNC team’s study.  Their study was published in the April 12, 2012  online issue of the journal Immunity.

Coy, Allen, PhD, first author of the paper and a Research Associate at UNC Lineberger Comprehensive Cancer Center, explains, “The role of the alternate NF-Kappa B pathway was unexpected. We discovered that in the absence of NLRP12, the alternative NF-kappa B pathway was activated and promoted inflammation and cancer. This was a highly novel finding.  Additionally, we were able to identify two proteins that are regulated by the alternative NF-Kappa B pathway that appear to be correlated to cancer development.  Further studies will be directed at targeting these proteins to see if we can reduce the development of colitis-associated .”

Allen is a research associate in the laboratory of Jenny Ting, PhD. Ting, UNC Alumni Distinguished Professor of Microbiology and Immunology and director of the Inflammation Center at UNC, is a pioneer in the understanding of the NLR family of proteins. She is co-leader of UNC Lineberger’s immunology program and senior author of the Immunity paper.

There are over 24 distinct NLR proteins in humans and only about half are well characterized.  Allen says the next steps are to better define the contribution of these proteins to human diseases and identify other NLR proteins that may influence important cell signaling pathways in novel ways, such as those described here for NF-Kappa B.  

Explore further: Scientists describe new protein's role in immune response to pathogens

More information: Other UNC authors are: Justin Wilson, PhD, Monika Schneider, PhD, John D. Lich, PhD, Reid A. Roberts, MD/PhD graduate student, Janelle C. Arthur, PhD, Rita-Marie T. Woodford, PhD graduate student, Bekley K. Davis, PhD, Joshua M. Uronis, PhD, Hans Herfarth, MD, Christian Jobin, PhD, Arlin Rogers, DVM, PhD, and Jenny P-Y Ting. Funding for the study was provided by grants from the National Institutes of Health.

Related Stories

Scientists describe new protein's role in immune response to pathogens

June 28, 2011
The human immune system is a double-edged sword.  While it is finely adapted to fighting potentially deadly viruses, such as the H1N1 influenza, the mechanisms it uses to fight pathogens can have negative effects such ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.